Immunosuppressive Therapy in Older Cardiac Transplant Patients

By Arezu Zejnab Aliabadi   Andreas Oliver Zuckermann   Grimm Michael  

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 913-932

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients

By Moes Dirk Jan A.R.   Press Rogier R.   >  

Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. : 467-480

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients

By Santoro Ana   Felipe Claudia R   Tedesco-Silva Helio   Medina-Pestana Jose O   Struchiner Claudio J   Ojopi Elida B   Suarez-Kurtz Guilherme  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1293-1303

Future Medicine

Access to resources Recommend Favorite

Induction Immunosuppression in Kidney Transplant Recipients Older than 60 Years of Age: Safety and Efficacy of ATGAM®, OKT3® and Simulect®

By Michael Heifets   Muhammad I. Saeed   Mitten H. Parikh   Debra Sierka   Mysore S.A. Kumar  

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 747-756

Adis International

Access to resources Recommend Favorite

Immunosuppression in Elderly Renal Transplant Recipients: Are Current Regimens Too Aggressive?

By Meier-Kriesche H-U.   Kaplan B.  

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 751-759

Adis International

Access to resources Recommend Favorite